1. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status

   • María I. Nunez
   • John Ludes-Meyers
   • C. Marcelo Aldaz

   Report Pages: 99 - 105

2. A comparison of record linkage yield for health research using different variable sets

   • Michael S. Simon
   • Beth A. Mueller
   • Glenn Copeland

   Report Pages: 107 - 110

3. Breast cancer screening barriers and mammography completion in older minority women

   • Rosalie F. Young
   • Richard K. Severson

   Report Pages: 111 - 118

4. Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patients

   • Tomoo Inoue
   • Yasuhiro Tamaki
   • Shinzaburo Noguchi

   Report Pages: 119 - 125

5. Ultrasound criteria for ductal invasive breast cancer are modified by age, tumor size, and axillary lymph node status

   • Dirk O. Watermann
   • Clemens B. Tempfer
   • Elmar Stickeler

   Report Pages: 127 - 133

6. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

   • Lisa Rydén
   • Maria Stendahl
   • Göran Landberg

   Report Pages: 135 - 143

7. Breast hamartoma: a case report

   • Giovanna Gatti
   • Giovanni Mazzarol
   • Giuseppe Viale

   Report Pages: 145 - 147

8. Breast hamartoma: A Case Report

   • Giovanna Gatti
   • Giovanni Mazzarol
   • Alberto Luini

   Erratum Pages: E1 - E3

9. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry

   • Timothy M. Pawlik
   • Herbert Fritsche
   • Henry M. Kuerer

   Report Pages: 149 - 157

10. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology

    • Alberto Luini
    • Viviana Galimberti
    • Giovanni Paganelli

    Report Pages: 159 - 163

11. A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

    • Gunter von Minckwitz
    • Walter Jonat
    • Andreas Schneeweiss

    Report Pages: 165 - 172

12. Hazard rates of recurrence following diagnosis of primary breast cancer

    • Ismail Jatoi
    • Anna Tsimelzon
    • Susan G. Hilsenbeck

    Report Pages: 173 - 178

13. Automatic ultrasound segmentation and morphology based diagnosis of solid breast tumors

    • Ruey-Feng Chang
    • Wen-Jie Wu
    • Dar-Ren Chen

    Report Pages: 179 - 185

14. Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory

    • Kathy D. Miller
    • Sharon E. Soule
    • George W. Sledge Jr

    Report Pages: 187 - 197

15. cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion

    • Yan-gao Man
    • Yi Zhang
    • Brian L Strauss

    Report Pages: 199 - 208

16. Inhibition of metastasis by inhibition of tumor-derived CCL5

    • Kerry A. Stormes
    • Charles A. Lemken
    • Robert A. Kurt

    Brief communication Pages: 209 - 212

17. Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer

    • Kadri Altundag
    • Ozden Altundag
    • Mehmet Gunduz

    Letter to the editor Pages: 213 - 213